Phase II trials of idarubicin, a new anthracycline

Chemioterapia. 1987 Jun;6(2 Suppl):694.
No abstract available

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Drug Evaluation
  • Female
  • Humans
  • Idarubicin / therapeutic use
  • Idarubicin / toxicity*
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged

Substances

  • Idarubicin